Celecoxib Prevents Doxorubicin-Induced Multidrug Resistance in Canine and Mouse Lymphoma Cell Lines
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Celecoxib Prevents Doxorubicin-Induced Multidrug Resistance in Canine and Mouse Lymphoma Cell Lines
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 5, Pages 1117
Publisher
MDPI AG
Online
2020-04-30
DOI
10.3390/cancers12051117
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Multiple ABCB1 transcriptional fusions in drug resistant high-grade serous ovarian and breast cancer
- (2019) Elizabeth L. Christie et al. Nature Communications
- Evaluation of Pgp (MDR1) immunohistochemistry in canine lymphoma – prognostic and clinical aspects
- (2018) Péter Vajdovich et al. ACTA VETERINARIA HUNGARICA
- Rechallenge with BRAF-directed treatment in metastatic melanoma: A multi-institutional retrospective study
- (2018) Sara Valpione et al. EUROPEAN JOURNAL OF CANCER
- Combination Chlorambucil/Firocoxib or Chlorambucil/Prednisolone Treatment for Inflammatory Colorectal Polyps in Miniature Dachshunds
- (2018) Akira Murakami et al. JOURNAL OF THE AMERICAN ANIMAL HOSPITAL ASSOCIATION
- The histone deacetylase inhibitor panobinostat is a potent antitumor agent in canine diffuse large B-cell lymphoma
- (2018) Joana N.R. Dias et al. Oncotarget
- Pegylated liposomal formulation of doxorubicin overcomes drug resistance in a genetically engineered mouse model of breast cancer
- (2017) András Füredi et al. JOURNAL OF CONTROLLED RELEASE
- Collateral sensitivity networks reveal evolutionary instability and novel treatment strategies in ALK mutated non-small cell lung cancer
- (2017) Andrew Dhawan et al. Scientific Reports
- Identification and Validation of Compounds Selectively Killing Resistant Cancer: Delineating Cell Line–Specific Effects from P-Glycoprotein–Induced Toxicity
- (2016) András Füredi et al. MOLECULAR CANCER THERAPEUTICS
- The Therapeutic Potential of AN-7, a Novel Histone Deacetylase Inhibitor, for Treatment of Mycosis Fungoides/Sezary Syndrome Alone or with Doxorubicin
- (2016) Lilach Moyal et al. PLoS One
- Histone deacetylase inhibitors in hematological malignancies and solid tumors
- (2015) Pusoon Chun ARCHIVES OF PHARMACAL RESEARCH
- ABCB1 in children's brain tumours
- (2015) B. Coyle et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Celecoxib exerts antitumor effects in canine mammary tumor cells via COX-2-independent mechanisms
- (2015) DAI TAMURA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- P-Glycoprotein Mediated Drug Interactions in Animals and Humans with Cancer
- (2015) K.L. Mealey et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- Histone Deacetylase Inhibitors (HDACi) Cause the Selective Depletion of Bromodomain Containing Proteins (BCPs)
- (2015) Marie-Therese Mackmull et al. MOLECULAR & CELLULAR PROTEOMICS
- Efficacy of Combined Histone Deacetylase and Checkpoint Kinase Inhibition in a Preclinical Model of Human Burkitt Lymphoma
- (2015) YanGuo Kong et al. MOLECULAR MEDICINE
- The long-acting COX-2 inhibitor mavacoxib (Trocoxil™) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro
- (2014) Lisa Y Pang et al. BMC Veterinary Research
- An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia
- (2014) Birgit Knoechel et al. NATURE GENETICS
- Multi-drug resistance in a canine lymphoid cell line due to increased P-glycoprotein expression, a potential model for drug-resistant canine lymphoma
- (2014) M. Zandvliet et al. TOXICOLOGY IN VITRO
- Overcoming multiple drug resistance mechanisms in medulloblastoma
- (2014) Ramadhan T Othman et al. Acta Neuropathologica Communications
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- MDR1 mRNA expression and MDR1 gene variants as predictors of response to chemotherapy in patients with acute myeloid leukaemia: a meta-analysis
- (2013) Chrysoula Doxani et al. BIOMARKERS
- Expression and role of PGP, BCRP, MRP1 and MRP3 in multidrug resistance of canine mammary cancer cells
- (2013) Karol M Pawłowski et al. BMC Veterinary Research
- Canine Lymphomas
- (2013) V. E. Valli et al. VETERINARY PATHOLOGY
- Non-Darwinian dynamics in therapy-induced cancer drug resistance
- (2013) Angela Oliveira Pisco et al. Nature Communications
- Impact of Intertumoral Heterogeneity on Predicting Chemotherapy Response of BRCA1-Deficient Mammary Tumors
- (2012) S. Rottenberg et al. CANCER RESEARCH
- The dog as a possible animal model for human non-Hodgkin lymphoma: a review
- (2012) Laura Marconato et al. HEMATOLOGICAL ONCOLOGY
- Side Population Cells from Human Melanoma Tumors Reveal Diverse Mechanisms for Chemoresistance
- (2012) Yuchun Luo et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- P-glycoprotein expression in canine mammary gland tumours related with myoepithelial cells
- (2012) N.-H. Kim et al. RESEARCH IN VETERINARY SCIENCE
- Overexpression of P-glycoprotein, STAT3, phospho-STAT3 and KIT in spontaneous canine cutaneous mast cell tumours before and after prednisolone treatment
- (2012) Shr-Ping Teng et al. VETERINARY JOURNAL
- COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer
- (2011) Hua Sui et al. CARCINOGENESIS
- Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatment
- (2011) A. Becker et al. EUROPEAN JOURNAL OF CANCER
- Clinical Relevance of Multidrug Resistance Gene Expression in Ovarian Serous Carcinoma Effusions
- (2011) Jean-Pierre Gillet et al. MOLECULAR PHARMACEUTICS
- Sensitive and Specific Fluorescent Probes for Functional Analysis of the Three Major Types of Mammalian ABC Transporters
- (2011) Irina V. Lebedeva et al. PLoS One
- A Chromatin-Mediated Reversible Drug-Tolerant State in Cancer Cell Subpopulations
- (2010) Sreenath V. Sharma et al. CELL
- Immunohistochemical Detection of Proteins Associated with Multidrug Resistance to Anti-Cancer Drugs in Canine and Feline Primary Pulmonary Carcinoma
- (2010) Tatsuro HIFUMI et al. JOURNAL OF VETERINARY MEDICAL SCIENCE
- Establishment and characterization of a novel canine B-cell line derived from a spontaneously occurring diffuse large cell lymphoma
- (2010) Barbara C. Rütgen et al. LEUKEMIA RESEARCH
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- Celecoxib inhibits MDR1 expression through COX-2-dependent mechanism in human hepatocellular carcinoma (HepG2) cell line
- (2009) Karnati R. Roy et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Moderate Increase in Mdr1a/1b Expression Causes In vivo Resistance to Doxorubicin in a Mouse Model for Hereditary Breast Cancer
- (2009) M. Pajic et al. CANCER RESEARCH
- Bmi-1gene is upregulated in early-stage hepatocellular carcinoma and correlates with ATP-binding cassette transporter B1 expression
- (2009) Kathryn Effendi et al. CANCER SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started